Drug Profile
Research programme: antibacterials - NewBiotics
Alternative Names: Lamectacin; NB 2001; NB 2030; NB 3179; NB 3180; NB 3322; NB-2179Latest Information Update: 10 Jun 2005
Price :
$50
*
At a glance
- Originator NewBiotics
- Class
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections; Nosocomial infections
Most Recent Events
- 10 Jun 2005 Discontinued - Preclinical for Bacterial infections in USA (unspecified route)
- 10 Jun 2005 Discontinued - Preclinical for Nosocomial infections in USA (unspecified route)
- 26 Jul 2004 NewBiotics has been acquired by Celmed BioSciences